Portal Biotechnologies
PrivateLast Round
Series A
Jun 30, 2025
Total Funding Raised
$35M
Momentum Score
25 /100
Company Overview
Portal Biotechnologies is a cell engineering platform company that provides technology for intracellular delivery. Founded in 2023 by Armon Sharei, the former CEO of SQZ Biotechnologies, the company focuses on a simplified, mechanical approach to deliver a wide range of cargo—such as RNA, polypeptides, and gene editing complexes—into various cell types. This technology is designed to enable and accelerate new applications in biological research and the development of cell therapies. The company offers its platform to biopharma companies, academic institutions, and equipment manufacturers.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Portal Biotechnologies Comps
Public and private peers based on sector, stage, and business model.
Portal Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 30, 2025 |
Key People
Founding team and executive leadership
Portal Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SCVC | Series A |
| British Business Bank | Series A |
| Amino Collective | Series A |
| NATO Innovation Fund | Series A |
| Pillar VC | Series A |
| Earlybird Venture Capital | Series A |
| 8VC | Series A |
Portal Biotechnologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Portal Biotechnologies's valuation, stock price, and market status.
